Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 29251-29300 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06145919
Parent-Child Memory Study: Improving Future Thinking Among Mothers
NARecruiting
144 participants
Started: Feb 6, 2024 · Completed: Aug 31, 2025
1 condition4 sponsors1 location
NCT06062303
Hemodynamic Phenotype-Based,Capillary Refill Time-Targeted Resuscitation In Early Septic Shock:ANDROMEDA-SHOCK-2
NARecruiting
180 participants
Started: Feb 6, 2024 · Completed: May 30, 2026
2 conditions1 sponsor1 location
NCT06262880
Dietary Supplementation on Gastrointestinal Barrier Function
NARecruiting
126 participants
Started: Feb 6, 2024 · Completed: Feb 6, 2025
1 condition1 sponsor1 location
NCT06158958
A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid Tumors
PHASE1Recruiting
192 participants
Started: Feb 6, 2024 · Completed: Jan 31, 2028
1 condition1 sponsor18 locations
NCT06243263
Postoperative Pain After Bupivacaine Supplementation in Mandibular Fracture Surgery
PHASE4Recruiting
30 participants
Started: Feb 6, 2024 · Completed: Mar 4, 2024
4 conditions1 sponsor2 locations
NCT05943665
MDMA for AUD/PTSD Comorbidity
PHASE2Recruiting
18 participants
Started: Feb 6, 2024 · Completed: Jan 30, 2026
2 conditions1 sponsor1 location
NCT06259279
High Impact Training to Patients with Prostate Cancer and Bone Metastases
NARecruiting
102 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06102330
Multicenter HomeVENT: Home Values and Experiences Navigation Track
NARecruiting
600 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2030
3 conditions2 sponsors4 locations
NCT06273761
Evaluation of Medication Management Service
NARecruiting
640 participants
Started: Feb 6, 2024 · Completed: May 1, 2027
6 conditions10 sponsors8 locations
NCT06247345
A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01
PHASE1Recruiting
73 participants
Started: Feb 6, 2024 · Completed: Feb 28, 2026
1 condition2 sponsors4 locations
NCT06152185
Mindfulness App Training for Cardiovascular Health
NARecruiting
105 participants
Started: Feb 6, 2024 · Completed: Apr 30, 2026
2 conditions2 sponsors1 location
NCT06777771
Effects of Reformer Pilates in Pregnant Women
NARecruiting
30 participants
Started: Feb 6, 2024 · Completed: Sep 30, 2025
5 conditions1 sponsor1 location
NCT06883942
Pilot Study on the Evaluation of the Functionality, Safety and Reliability of New Tripping Devices for Lower Limbs.
N/ARecruiting
30 participants
Started: Feb 6, 2024 · Completed: Jun 30, 2025
3 conditions2 sponsors1 location
NCT06751121
Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori
PHASE3Recruiting
460 participants
Started: Feb 6, 2024 · Completed: Jun 30, 2026
3 conditions2 sponsors1 location
NCT06586021
Evaluation of the Aortoseal™ for Sealing and Fixation of AAA Endovascular Grafts to Aortic Wall
NARecruiting
25 participants
Started: Feb 6, 2024 · Completed: Nov 1, 2029
1 condition1 sponsor1 location
NCT06262438
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
PHASE2Recruiting
60 participants
Started: Feb 6, 2024 · Completed: Jun 30, 2032
1 condition2 sponsors1 location
NCT06525168
Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on DA414
PHASE1Recruiting
82 participants
Started: Feb 6, 2024 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05868629
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
N/ARecruiting
40 participants
Started: Feb 6, 2024 · Completed: May 4, 2028
1 condition1 sponsor6 locations
NCT06246110
A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC
PHASE2Recruiting
70 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor39 locations
NCT06395922
Blockbuster LMA Versus Baska Mask in Laparoscopic Cholecystectomy
NARecruiting
140 participants
Started: Feb 6, 2024 · Completed: Jun 1, 2024
3 conditions1 sponsor1 location
NCT06259513
Omission of Axillary Surgery in Breast Cancer Patients
NARecruiting
350 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2033
3 conditions1 sponsor1 location
NCT06238544
Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria
PHASE2Recruiting
120 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor2 locations
NCT05542069
Measurement of the Diaphragm Loading During the Training With a IMT Device
N/ARecruiting
10 participants
Started: Feb 6, 2024 · Completed: Mar 30, 2025
1 condition1 sponsor1 location
NCT06992986
Urinary Microbiome Differences in Bladder Cancer, Benign Urinary Diseases and Healthy Counterparts in Adult Male Population
N/ARecruiting
50 participants
Started: Feb 6, 2024 · Completed: Jul 6, 2025
1 condition1 sponsor1 location
NCT06224933
Augmented Reality For MRI-Guided Interventions
NARecruiting
25 participants
Started: Feb 6, 2024 · Completed: May 31, 2026
3 conditions1 sponsor1 location
NCT06225726
Elastographic Analysis of Urothelial Bladder Tumours
N/ARecruiting
50 participants
Started: Feb 6, 2024 · Completed: Feb 28, 2025
2 conditions1 sponsor1 location
NCT06377267
Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial)
PHASE2Recruiting
100 participants
Started: Feb 6, 2024 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT06017856
Physical Exercise and Nutrition in Functional Gastrointestinal Disorders in Obese Children
N/ARecruiting
180 participants
Started: Feb 6, 2024 · Completed: Nov 30, 2024
2 conditions1 sponsor1 location
NCT06112704
HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors
PHASE2Recruiting
220 participants
Started: Feb 6, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor21 locations
NCT05711615
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
PHASE1Recruiting
30 participants
Started: Feb 6, 2024 · Completed: May 3, 2026
12 conditions1 sponsor16 locations
NCT06031714
Fetal Cell Receptors Repertoire
NARecruiting
160 participants
Started: Feb 6, 2024 · Completed: Feb 1, 2027
5 conditions2 sponsors1 location
NCT06138509
Peripheral Serotonin and Albinism
N/ARecruiting
160 participants
Started: Feb 6, 2024 · Completed: Feb 28, 2026
1 condition2 sponsors1 location
NCT06222723
LAssa Fever Adjunct Treatment With DEXamethasone
PHASE2Recruiting
42 participants
Started: Feb 5, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06118697
Feasibility of Aerodigestive Stimulation Therapy Trial
NARecruiting
40 participants
Started: Feb 5, 2024 · Completed: Nov 1, 2027
1 condition1 sponsor1 location
NCT06562478
Effects of Zazen Meditation in Patients With Acute Myocardial Infarction - Randomized Clinical Trial
NARecruiting
44 participants
Started: Feb 5, 2024 · Completed: Jul 31, 2026
2 conditions1 sponsor1 location
NCT06257355
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Corneal Scars
PHASE1Recruiting
20 participants
Started: Feb 5, 2024 · Completed: Jan 31, 2026
1 condition1 sponsor7 locations
NCT06257030
The AMARA (As Much As Reasonably Achievable) Study
N/ARecruiting
100 participants
Started: Feb 5, 2024 · Completed: Feb 5, 2027
1 condition1 sponsor1 location
NCT06286462
Evaluation of the Cancer Tracking System (CATSystem)
NARecruiting
6,600 participants
Started: Feb 5, 2024 · Completed: Aug 31, 2028
1 condition5 sponsors10 locations
NCT05910827
Study of an Anti-HER3 Antibody, HMBD-001, With Docetaxel +/- Cetuximab in Advanced Squamous Non-small Cell Lung Cancers, and HMBD-001 + Cetuximab in Advanced Squamous Cell Cancers
PHASE1/PHASE2Recruiting
98 participants
Started: Feb 5, 2024 · Completed: Mar 1, 2026
5 conditions2 sponsors20 locations
NCT06229158
Assessment of the Quality and Sexual Health Needs of Patients with Advanced-stage Cancer
N/ARecruiting
120 participants
Started: Feb 5, 2024 · Completed: Apr 30, 2025
2 conditions1 sponsor3 locations
NCT05875571
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
PHASE4Recruiting
18 participants
Started: Feb 5, 2024 · Completed: Jun 30, 2025
4 conditions1 sponsor1 location
NCT06260215
Recovery Kinetics Following a Soccer Training in Middle-aged Males
NARecruiting
11 participants
Started: Feb 5, 2024 · Completed: Mar 9, 2024
1 condition1 sponsor1 location
NCT06695559
Non-surgical Treatment of Peri-implantitis Using Chitosan Brush and Tetracycline Slurry
PHASE4Recruiting
40 participants
Started: Feb 5, 2024 · Completed: Feb 5, 2025
2 conditions1 sponsor1 location
NCT06146855
Amnion Membrane Versus DFGG Using the Tunneling Technique in Management of Gingival Recession Defects.
NARecruiting
22 participants
Started: Feb 5, 2024 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT06002217
Echo-guided Transverse Abdominal Plane Block (TAP) in Anterior Lumbar Arthrodesis (ALIF)
NARecruiting
80 participants
Started: Feb 5, 2024 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT06191744
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma
PHASE3Recruiting
1,095 participants
Started: Feb 5, 2024 · Completed: Nov 30, 2037
1 condition2 sponsors249 locations
NCT05006404
Autus Valve Pivotal Study
NARecruiting
50 participants
Started: Feb 5, 2024 · Completed: Feb 29, 2036
1 condition1 sponsor12 locations
NCT05776056
Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints
PHASE4Recruiting
70 participants
Started: Feb 5, 2024 · Completed: Mar 31, 2027
1 condition1 sponsor3 locations
NCT06288763
Nerve Transfer to Improve Function in High Level Tetraplegia
N/ARecruiting
30 participants
Started: Feb 5, 2024 · Completed: Dec 31, 2028
2 conditions11 sponsors9 locations
NCT06247670
Study of CMP-CPS-001 in Healthy Volunteers
PHASE1Recruiting
96 participants
Started: Feb 5, 2024 · Completed: Aug 31, 2025
1 condition1 sponsor1 location